FDA Orange Book · active-ingredient family
Esmolol hydrochloride
Esmolol hydrochloride is approved as 2 brand and 11 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER · NDA 205703
2
Brand (NDA)
11
Generics (ANDA)
2
Listed patents
0
Exclusivity periods
Brand (NDA) products · injectable, solution
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINERRLD×2 | HQ SPCLT PHARMA | NDA 205703 | — | Apr 07, 2016 | |
| BREVIBLOCRLD×5 | BAXTER HLTHCARE | NDA 019386 | AP | Feb 25, 2003 |
Generic (ANDA) products (11)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| ESMOLOL HYDROCHLORIDE×2 | AMNEAL | ANDA 216603 | AP | Dec 13, 2022 | |
| ESMOLOL HYDROCHLORIDE×2 | HQ SPCLT PHARMA | ANDA 214172 | AP | Dec 02, 2022 | |
| ESMOLOL HYDROCHLORIDE×2 | EUGIA PHARMA | ANDA 216244 | AP | Mar 21, 2022 | |
| ESMOLOL HYDROCHLORIDE | GLAND | ANDA 208538 | AP | Aug 14, 2019 | |
| ESMOLOL HYDROCHLORIDE×2 | MYLAN LABS LTD | ANDA 206608 | AP | Jun 08, 2018 | |
| ESMOLOL HYDROCHLORIDE×2 | SAGENT PHARMS INC | ANDA 207107 | AP | Jun 08, 2018 | |
| ESMOLOL HYDROCHLORIDE | EUGIA PHARMA | ANDA 205520 | AP | Jul 23, 2015 | |
| ESMOLOL HYDROCHLORIDE | AM REGENT | ANDA 201126 | — | Feb 20, 2015 | |
| ESMOLOL HYDROCHLORIDE×2 | FRESENIUS KABI USA | ANDA 076573 | — | May 02, 2005 | |
| ESMOLOL HYDROCHLORIDE | MYLAN INSTITUTIONAL | ANDA 076474 | AP | May 02, 2005 | |
| ESMOLOL HYDROCHLORIDE | HIKMA | ANDA 076323 | AP | Aug 10, 2004 |
Listed patents (2)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8835505 | Mar 15, 2033 | in 6 yr 10 mo | Product |
| 8829054 | Mar 15, 2033 | in 6 yr 10 mo | Product |
Esmolol hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

